Luxna Biotech Co., Ltd. is pleased to announce that it has entered into a license agreement with Inabata & Co., Ltd. (President: Katsutaro Inabata, Headquarters: Osaka City, Osaka Prefecture, Japan) regarding the manufacture and sale of synthetic modified nucleic acid amidite GuNA™.

For more details, please click here.